Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TEH, L. S.
Right arrow Articles by WILLIAMS, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TEH, L. S.
Right arrow Articles by WILLIAMS, B. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 British Society for Rheumatology

other

ANTI-P ANTIBODIES ARE ASSOCIATED WITH PSYCHIATRIC AND FOCAL CEREBRAL DISORDERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

L. S. TEH, E. M. HAY*, N. AMOS, D. BLACK{dagger}, A. HUDDY{dagger}, F. CREED{dagger}, R. M. BERNSTEIN*, P. J. L. HOLT* and B. D. WILLIAMS

Rheumatology Research Centre, University Hospital of Wales Heath Park, Cardiff
*University Departments of Rheumatology, Manchesrer Royal Infirmary Manchester
{dagger}Psychiatry, Manchesrer Royal Infirmary Manchester

Correspondence to: Correspondence to L. S. Teh, Rheumatology Research Centre, University Hospital of Wales, Heath Park, Cardiff CF4 4XW

In a cross-sectional study, 62 patients with systemic lupus erythematosus were assessed using standardized psychiatric and psychological methods; systemic disease activity was scored using the British Isles Lupus Assessment Group and the Lupus Activity Criteria Count indices IgG and IgM anti-P antibodies were measured by ELISA using a synthetic 22 amino acid peptide as the relevant antigen. IgG and IgM anti-P antibodies were significantly associated with neuropsychiatric disorders (psychiatric and neurological) but failed to distinguish patients with psychiatric disorders from those with neurological disorders. These antibodies were not associated with cognitive impairment or systemic disease activity.

KEY WORDS: Systemic lupus erythematosus (SLE), Neuropsychiatric (psychiatric or neurological), Anti-P antibody


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. Haddouk, S. Marzouk, M. Jallouli, H. Fourati, M. Frigui, Y. B. H. Hmida, F. Koubaa, W. Sellami, S. Baklouti, J. Hachicha, et al.
Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus
Rheumatology, August 1, 2009; 48(8): 953 - 957.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
S.M. Benseler and E.D. Silverman
Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus
Lupus, August 1, 2007; 16(8): 564 - 571.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Gerli, L. Caponi, A. Tincani, R. Scorza, M. G. Sabbadini, M. G. Danieli, V. De Angelis, M. Cesarotti, M. Piccirilli, R. Quartesan, et al.
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients
Rheumatology, December 1, 2002; 41(12): 1357 - 1366.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
G Sanna, M Piga, J W Terryberry, M T Peltz, S Giagheddu, L Satta, A Ahmed, A Cauli, C Montaldo, G Passiu, et al.
Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations
Lupus, October 1, 2000; 9(8): 573 - 583.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.